Gynecologie Obstetrique Fertilite & Senologie, published by ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, serves as a crucial resource for researchers and practitioners in the fields of obstetrics, gynecology, and reproductive medicine. Established in 2017 and continuing through 2024, this journal provides a platform for the dissemination of impactful research, evidenced by its placement in the Q3 category for both obstetrics and gynecology and reproductive medicine in 2023. Although it currently does not operate under an open-access model, the journal is committed to advancing knowledge and practice in women's health and reproductive issues, ensuring that professionals stay at the forefront of scientific developments. With an ISSN of 2468-7197 and an E-ISSN of 2468-7189, the journal not only supports the global medical community from its base in France but also contributes to the broader academic discourse on critical topics such as fertility and women's health. As researchers and professionals in the field seek to enhance their understanding and impact, Gynecologie Obstetrique Fertilite & Senologie remains an essential publication for quality research and innovative solutions in women’s health.

Revista Brasileira de Ginecologia e Obstetricia is a renowned academic journal based in Brazil, published by GEORG THIEME VERLAG KG, dedicated to advancing research in the fields of gynecology and obstetrics. With an Open Access policy since 1998, this journal ensures that critical findings and insights remain accessible to a global audience, fostering collaboration and knowledge sharing among healthcare professionals and researchers. The journal has maintained a respectable position within its field, currently ranked Q3 in Obstetrics and Gynecology according to the 2023 category quartiles, and holds a Scopus rank of 122 out of 209, placing it in the 41st percentile. Covering a wide array of topics pertinent to women's health, the Revista Brasileira de Ginecologia e Obstetricia serves as a vital platform for disseminating new research, clinical practices, and reviews, contributing to the enhanced understanding and treatment of gynecological and obstetrical conditions. The journal not only supports academic rigor but also empowers professionals and students in their pursuit of excellence in women's health.

GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.

European Journal of Obstetrics & Gynecology and Reproductive Biology-X, published by ELSEVIER, serves as a pivotal platform in the fields of obstetrics, gynecology, and reproductive biology. With an ISSN of 2590-1613, this journal has developed a notable presence since its transition to Open Access in 2019, enabling wider dissemination of research findings and fostering collaboration across disciplines. Located in Amsterdam, Netherlands, this journal holds a commendable Q2 ranking in both Obstetrics and Gynecology and Reproductive Medicine categories for 2023, reflecting its impact and relevance in the scientific community. Researchers and practitioners can access cutting-edge studies and reviews, contributing to advancements in reproductive health and clinical practices. With a focus on innovative research and evidence-based practices, the European Journal of Obstetrics & Gynecology and Reproductive Biology-X is committed to bridging the gap between laboratory discoveries and the application in clinical settings, making it an essential resource for those dedicated to enhancing reproductive health outcomes.

Clinical and Experimental Obstetrics & Gynecology is a prominent journal published by IMR PRESS, dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Since its establishment in 1974, this journal has been a crucial platform for the dissemination of research findings, innovative practices, and reviews that contribute to the advancement of women's health. With an Open Access model adopted in 2019, it ensures that high-quality research is accessible to all stakeholders in the field, thus promoting greater collaboration and knowledge sharing. Based in Hong Kong, the journal is indexed under various categories with a 2023 Quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine, affirming its role in shaping the academic conversation within these disciplines. Despite its current Scopus rankings placing it in the lower percentiles, the journal continues to grow in influence, making it an essential resource for researchers, healthcare professionals, and students aiming to stay at the forefront of clinical and experimental innovations in obstetrics and gynecology.

Middle East Fertility Society Journal is a premier open-access publication established in 1996 that caters to the fields of Obstetrics and Gynecology as well as Reproductive Medicine. Published by SPRINGER in Egypt, this journal has made significant strides in disseminating high-quality research and advancements in reproductive health, achieving a 2023 Scopus rank of #102 in Obstetrics and Gynecology and #47 in Reproductive Medicine, placing it in the 51st and 48th percentiles respectively. With an aim to foster collaboration and innovation in the fertility sector, it welcomes researchers and practitioners to share their findings and insights, contributing to the global discourse on reproductive issues. As an open-access journal since 2010, it ensures that the latest research is readily available to a broad audience, enhancing accessibility and knowledge transfer in the vital area of reproductive health.

African Journal of Reproductive Health, published by the WOMENS HEALTH & ACTION RESEARCH CENTRE, is a vital resource for researchers and practitioners in the fields of obstetrics, gynecology, and reproductive health. This journal, with ISSN 1118-4841 and E-ISSN 2141-3606, has been contributing to the academic discourse since its inception in 1997, offering insightful research and evidence-based articles that address pressing reproductive health issues in Africa and beyond. With a Q3 category ranking in essential areas such as Obstetrics and Gynecology, Public Health, and Reproductive Medicine, the journal is positioned in the 34th to 30th percentile among its peers, reflecting its commitment to high-quality scholarship. Despite its classification as a non-open access journal, the publication remains accessible to a diverse audience, fostering knowledge exchange in reproductive health. The African Journal of Reproductive Health serves as a crucial platform for emerging and established researchers to disseminate their findings, enhancing the understanding of reproductive health challenges and solutions in the African context.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

Human Reproduction Open, published by Oxford University Press, is a prestigious open-access journal dedicated to advancing the field of reproductive health and medicine since its inception in 2017. With an E-ISSN of 2399-3529, the journal provides a vital platform for researchers, clinicians, and academics to disseminate innovative findings in obstetrics, gynecology, and reproductive medicine. It is recognized for its impactful contributions, holding an impressive rank of #3 out of 209 in Medicine - Obstetrics and Gynecology, #2 out of 90 in Medicine - Reproductive Medicine, and #1 out of 21 in Medicine - Embryology, placing it in the top percentiles of its respective categories. The open-access model ensures that research is freely accessible, fostering collaboration and knowledge sharing among professionals and students alike. With a commitment to high-quality, peer-reviewed publications, Human Reproduction Open plays a crucial role in shaping the future of reproductive health research and practice, serving as an essential resource for those dedicated to improving outcomes in this dynamic field.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.